Start an analysis for ANF
Abercrombie & Fitch Co.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $1.3bn | 01-Aug-26 | 10-Q filed 04-Sep-26 |
| Remaining authorization | $568m | 01-Aug-26 | 10-Q filed 04-Sep-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $213m | 01-Aug-26 | 10-Q filed 04-Sep-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 05-Mar-25 | $1.3bn | $568m | n/a | On March 5, 2025, the Company announced that the Board of Directors approved a new $1.3 billion share repurchase program (the '2025 Authorization'), which replaced the prior share repurchase authorization of $500 million that was approved by the Board of Directors in 2021 (the '2021 Authorization'). The 2025 Authorization does not have an expiration date.10-Q filed 04-Sep-26 |
Open-market repurchases
- May ’26
- Jul ’26
- Aug ’26
| Month ended | Shares | Withheld & other | Avg price | ≈ Value | Source |
|---|---|---|---|---|---|
| 01-Aug-26 | 495,715 | 277 | $91.00 | $45m | 10-Q filed 04-Sep-26 |
| 04-Jul-26 | 1,520,859 | 859 | $86.85 | $132m | 10-Q filed 04-Sep-26 |
| 30-May-26 | 500,000 | 500,000 | $70.75 | $35m | 10-Q filed 04-Sep-26 |